Zimmer Biomet Holdings ROE 2006-2018 | ZBH

Current and historical return on equity (ROE) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Zimmer Biomet Holdings ROE for the three months ending December 31, 2018 was 13.17%.
Zimmer Biomet Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $-0.38B $11.28B -3.19%
2018-09-30 $1.75B $12.22B 14.61%
2018-06-30 $1.69B $12.04B 14.62%
2018-03-31 $1.69B $12.00B 15.19%
2017-12-31 $1.81B $11.74B 17.10%
2017-09-30 $0.65B $10.45B 6.47%
2017-06-30 $0.71B $10.28B 7.19%
2017-03-31 $0.50B $9.93B 5.11%
2016-12-31 $0.31B $9.67B 3.18%
2016-09-30 $0.36B $9.75B 3.75%
2016-06-30 $0.23B $9.55B 2.32%
2016-03-31 $0.08B $9.66B 0.85%
2015-12-31 $0.15B $9.89B 1.60%
2015-09-30 $0.17B $9.99B 2.02%
2015-06-30 $0.32B $10.13B 4.28%
2015-03-31 $0.67B $6.58B 10.26%
2014-12-31 $0.72B $6.55B 11.19%
2014-09-30 $0.83B $6.54B 12.96%
2014-06-30 $0.81B $6.45B 12.86%
2014-03-31 $0.78B $6.24B 12.75%
2013-12-31 $0.78B $6.30B 12.98%
2013-09-30 $0.68B $6.14B 11.49%
2013-06-30 $0.70B $5.89B 12.05%
2013-03-31 $0.77B $5.71B 13.23%
2012-12-31 $0.76B $5.87B 13.11%
2012-09-30 $0.76B $5.83B 13.38%
2012-06-30 $0.77B $5.71B 13.76%
2012-03-31 $0.76B $5.66B 13.38%
2011-12-31 $0.76B $5.52B 13.25%
2011-09-30 $0.64B $5.61B 11.01%
2011-06-30 $0.64B $6.02B 10.89%
2011-03-31 $0.60B $5.86B 10.37%
2010-12-31 $0.60B $5.77B 10.36%
2010-09-30 $0.72B $5.82B 12.52%
2010-06-30 $0.68B $5.74B 11.72%
2010-03-31 $0.72B $5.71B 12.45%
2009-12-31 $0.72B $5.64B 12.48%
2009-09-30 $0.73B $5.98B 12.70%
2009-06-30 $0.80B $5.81B 14.05%
2009-03-31 $0.81B $5.56B 14.54%
2008-12-31 $0.85B $5.65B 15.10%
2008-09-30 $0.95B $5.62B 16.96%
2008-06-30 $0.78B $5.51B 14.15%
2008-03-31 $0.78B $5.71B 14.38%
2007-12-31 $0.77B $5.45B 14.67%
2007-09-30 $0.76B $5.25B 14.68%
2007-06-30 $0.89B $5.28B 17.75%
2007-03-31 $0.86B $5.12B 17.47%
2006-12-31 $0.84B $4.92B 17.09%
2006-09-30 $0.79B $4.80B 16.37%
2006-06-30 $0.78B $4.90B 16.33%
2006-03-31 $0.77B $4.92B 16.64%
2005-12-31 $0.73B $4.68B 16.64%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.222B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.164B 26.13
Medtronic (MDT) Ireland $123.923B 18.53
Stryker (SYK) United States $69.625B 25.56
Boston Scientific (BSX) United States $55.366B 27.03
Baxter (BAX) United States $39.075B 24.08
Smith & Nephew SNATS (SNN) United Kingdom $16.659B 0.00
ResMed (RMD) United States $14.394B 27.30
Canopy Growth (CGC) Canada $11.042B 0.00
Bio-Rad Laboratories (BIO) United States $8.100B 51.79
Aurora Cannabis (ACB) Canada $7.040B 50.36
Hill-Rom Holdings (HRC) United States $6.974B 21.57
Perrigo (PRGO) Ireland $6.650B 10.09
Insulet (PODD) United States $5.226B 0.00
ICU Medical (ICUI) United States $5.190B 28.91
GW Pharmaceuticals (GWPH) United Kingdom $4.539B 0.00
Haemonetics (HAE) United States $4.489B 39.82
Agios Pharmaceuticals (AGIO) United States $3.462B 0.00
Hutchison China MediTech (HCM) China $3.417B 0.00
Neogen (NEOG) United States $3.281B 50.39
NuVasive (NUVA) United States $3.013B 28.03
National Vision Holdings (EYE) United States $2.624B 50.75
Quidel (QDEL) United States $2.581B 23.28
Aphria (APHA) $2.402B 106.67
NxStage Medical (NXTM) United States $1.954B 0.00
AtriCure (ATRC) United States $1.279B 0.00
Phibro Animal Health (PAHC) United States $1.231B 17.70
VAREX IMAGING (VREX) United States $1.198B 23.45
Cardiovascular Systems (CSII) United States $1.170B 840.00
MacroGenics (MGNX) United States $0.923B 0.00
Cerus (CERS) United States $0.878B 0.00
PetIQ (PETQ) United States $0.837B 21.68
Surmodics (SRDX) United States $0.766B 111.39
Evolus (EOLS) United States $0.747B 0.00
NanoString Technologies (NSTG) United States $0.719B 0.00
Lantheus Holdings (LNTH) United States $0.713B 22.07
Meridian Bioscience (VIVO) United States $0.704B 20.98
OraSure Technologies (OSUR) United States $0.703B 31.03
Omeros (OMER) United States $0.688B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.625B 20.05
Quanterix (QTRX) United States $0.505B 0.00
LeMaitre Vascular (LMAT) United States $0.492B 24.18
Owens & Minor (OMI) United States $0.479B 5.42
TG Therapeutics (TGTX) United States $0.395B 0.00
Insys Therapeutics (INSY) United States $0.368B 0.00
Utah Medical Products (UTMD) United States $0.334B 21.65
BioLife Solutions (BLFS) United States $0.299B 404.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.293B 0.00
Bovie Medical (APYX) United States $0.279B 0.00
Vapotherm (VAPO) United States $0.276B 0.00
Cytosorbents (CTSO) United States $0.262B 0.00
Rockwell Medical (RMTI) United States $0.242B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.150B 0.00
Fonar (FONR) United States $0.143B 7.65
Chembio Diagnostics (CEMI) United States $0.119B 0.00
Chimerix (CMRX) United States $0.101B 0.00
United-Guardian (UG) United States $0.091B 18.98
Female Health (VERU) United States $0.084B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.33
Conatus Pharmaceuticals (CNAT) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 13.57